# Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker

> **NCT03830957** · NA · UNKNOWN · sponsor: **Rajaie Cardiovascular Medical and Research Center** · enrollment: 200 (estimated)

## Conditions studied

- Heart Failure
- CT Angiography
- Ischemic Cardiomyopathy
- Non-ischemic Cardiomyopathy
- Heart Failure, Systolic
- Heart Failure，Congestive
- Heart Failure, Diastolic
- Heart Rate Low

## Interventions

- **DRUG:** Ivabradine
- **DRUG:** Metoprolol

## Key facts

- **NCT ID:** NCT03830957
- **Lead sponsor:** Rajaie Cardiovascular Medical and Research Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-11-26
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2019-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03830957

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03830957, "Efficacy and Safety of Ivabradine to Reduce Heart Rate Prior to Coronary CT-angiography in Advanced Heart Failure: Comparison With β-Blocker". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03830957. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*